Anders Karlsson has extensive international experience in Life Science, both from pharmaceutical and medical technology companies. Anders was CEO and Country President of Novartis in Norway 2003 – 2006 and thereafter CEO of the medical technology companies AbSorber AB, Olerup International AB och Olerup SSP AB 2007-2011.
In May 2011, he was appointed CEO of Nasdaq-listed Allenex AB, that develops, manufactures and sells transplant diagnostics products globally. In 2016, Allenex was acquired by Nasdaq, USA- listed CareDx Inc. Since then, Karlsson has been President and Managing Director of CareDx International AB and responsible for global operations outside the US and part of the company’s global management team.
In addition to leading operational roles, Anders has also gained a broad national and international experience from board assignments within Life science companies.
Anders Karlsson holds a MBA from Henley Business School, University of Reading, UK and management education from London Business School and Harvard.
Holdings: 35, 000 shares
Warrants: 120, 000